Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Gary R. Lichtenstein, MD

Gary R. Lichtenstein, MD Physician

Director, Inflammatory Bowel Disease Center
Professor of Medicine at the Hospital of the University of Pennsylvania

Languages spoken:

  • French
  • Hebrew

Dr. Lichtenstein is a Penn Medicine employed physician.

About Dr. Gary R. Lichtenstein

Recognized annually in Philadelphia Magazine's Top Docs issue from 2004 through 2016

Recognized by America's Top Doctors, 2007, 2008, 2010, 2012-14

Recognized by Best Doctors in America 2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties

Specialty:

  • Gastroenterology

Programs & Centers:

Board Certification:

  • Gastroenterology, 1989
  • Internal Medicine, 1987

Clinical Expertise:

  • Anal Cancer
  • Bile Duct Cancer
  • Colon Cancer
  • Crohn's Disease
  • Esophageal Cancer
  • Gallbladder Cancer
  • Gastrointestinal Carcinoid Tumor
  • Liver Cancer
  • Neuroendocrine Tumors
  • Pancreatic Cancer
  • Rectal Cancer
  • Small Intestine Cancer
  • Stomach Cancer (Gastric Cancer)

Description of Clinical Expertise

Inflammatory Bowel Disease
Crohn's Disease
Ulcerative Colitis

Practice Locations and Appointments

  • Gastroenterology

    Perelman Center for Advanced Medicine South Pavilion, 4th Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Mount Sinai School of Medicine
Residency: Duke University Medical Center
Fellowship: Hospital of the University of Pennsylvania

Hospital Affiliation

Dr. Lichtenstein is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Medicine Radnor: Has privileges to perform procedures.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

My research focuses on inflammatory bowel disease specifically Crohn's disease and Ulcerative Colitis. My particular focuses include
1.) medical therapy of inflammatory bowel disease,
2.) safety of current medical therapy for IBD, and
3.) natural history of disease

Selected Publications:

Kotlyar D, Lewis JD, Beaugerie L,Tierney A, Brensinger CM, Gisbert, JP, Loftus E, Peyrin-Biroulet L, Blonski W, Van Domselaar M, Chaparro, M, Sandilya S, Bewtra M, Lichtenstein GR: Risk of Lymphoma among Inflammatory Bowel Disease Patients Treated with Azathioprine and 6-Mercaptopurine: Meta-Analysis of Referral Center Studies and Population-based Studies. Clinical Gastroenterology and Hepatology 13 (5): 847-858,2015.

John Wysocki, Gary R. Lichtenstein, Nabeel Khan: Efficacy of Thiopurines in Achieving Steroid Free Remission in Ulcerative Colitis Patients: A Population Cohort Study Gastroenterology 148 (4 Supplement 1): S 867,2015.

Prashant R. Mudireddy, Frank I. Scott, Alexandra Feathers, Ann Tierney, Gary R. Lichtenstein: Predictors of Early and Late Unplanned Re-Admissions in IBD Patients. Gastroenterology 148 (4 Suppkement 1): S262-S263,2015.

Elisabeth B. Cole, Ali Abbas, Gary R. Lichtenstein, Nabeel Khan.: Temporal Relationship Between Onset of Ulcerative Colitis and Diagnosis of Primary Sclerosing Cholangitis: A Nationwide Population Cohort Study. Gastroenterology 148 (4 Supplement 1): S-479,2015.

Maria Paula Henao, Meenakshi Bewtra, Mark T. Osterman, Faten Aberra, Frank I. Scott, Gary R. Lichtenstein, Jennifer Kraschnewski, James Lewis.: Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection. Gastroenterology 148 (4 Supplement 1): S-443,2015.

Prashant R. Mudireddy, Frank I. Scott, Gary R. Lichtenstein.: Unplanned Hospital Readmission: Rates and Causes in Patients With Inflammatory Bowel Disease: A Critical Analysis Gastroenterology 148 (4 Supplement 1): S-835,2015.

John Wysocki, Gary R. Lichtenstein, Nabeel Khan: Efficacy of Thiopurines in Achieving Mucosal Healing in Ulcerative Colitis Patients: A Population Cohort Analysis Gastroenterology 148 (4 Supplement 1): S-867,2015.

Gary R. Lichtenstein, Edward V. Loftus, Brian G. Feagan, David G. Binion, David Sen, Amanda Golembesky, Gordana Kosutic, Cem Kayhan, Marshall Spearman, Douglas C. Wolf, Scott D. Lee.: Evaluation of Real-World Risk of Malignancies in Crohn's Disease Patients Treated With Certolizumab Pegol: Results From the SECURE Registry. Gastroenterology 148 (4): S-236,2015.

Ravy K. Vajravelu, Mark T. Osterman, Faten Aberra, Gary R. Lichtenstein, James Lewis, Frank I. Scott: Predictors of Indeterminate QuantiFERON-TB Gold Testing in Inflammatory Bowel Disease and Impact on Clinical Outcomes Gastroenterology 148 (4 Supplement 1): S 253,2015.

Gary R. Lichtenstein, Brian G. Feagan, William Sandborn, Iram Hasan, Gordana Kosutic, Jason Coarse, Catherine H. Arendt, Marshall Spearman, Edward V. Loftus.: Serious Infectious Complications in Patients Treated With Certolizumab Pegol: A Pooled Analysis of 15 Crohn's Disease Global Clinical Trials. Gastroenterology 148 (4 Supplement 1): S-236,2015.

View all publications

Academic Contact Info

Hospital of the University of Pennsylvania
7th Floor Perelman Center, 7-South Perelman Center, Room 753
Gastroentetrology Division Offices
One Convention Avenue

Philadelphia, PA 19104
Phone: (215) 349-8222
Fax: (215) 349-5915
Patient appointments: 800-789-PENN (7366)

Related Links